Evidence and anecdotes: An analysis of human gene patenting controversies

Article Abstract:

A summary of dominant policy concerns and the events that have led to the debates of ethical, legal and economic aspects of gene patenting is presented. A systematic review of the content and timing of major policy documents highlight the fact that policy activity has been largely stimulated by a convergence of a general social unease, the emergence of preliminary data and literature on the possible adverse practical ramifications of gene patents, and several high-profile patent protection controversies.

Public affairs, Ethics, Ethical aspects, Genetic research

---

Privatizing biomedical research-a 'third way'

Article Abstract:

A reallocation scheme typified by the proposed compulsory government royalty (CGR) model to benefit society from publicly funded biomedical research is reviewed. The model serves to balance economic incentives and protect interest of for-profit entities.

Government expenditures, Research and Development in the Physical, Engineering, and Life Sciences, Research and Testing Services, Medical Research, Epilepsy & Muscle Disease R&D, Administration of Public Health Programs, Health Research Programs, Analysis, Royalties, Royalties (Intellectual property), Government finance, Intellectual property law, Medicine, Experimental

---

Similar abstracts:

• Abstracts: Price and volume effects of changes in MSCI indices - nature and causes
• Abstracts: ScanBalt coordinates intellectual property in Northern Europe. Rising biotech appetite in the east

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.